Georgetown University MS Biotechnology

What is Georgetown MS Biotechnology?

The full-time MS Biotechnology runs 10 months, requires 30 credits and focuses on laboratory biotechnology joined to BioBusiness, BioScience, cell and gene therapy, drug discovery or entrepreneurship tracks. Georgetown’s official programme page defines that route. The Indian planning total is INR 95.62 lakh at the stated conversion basis.

The academic sequence moves from Molecular Biotechnology through Experimental Biotechnology and BioBusiness toward Capstone or Internship, where project communication becomes assessed evidence. This record covers the full-time in-person route only. Admission, funding, professional licensing, employment and immigration remain separate decisions.

How much does Georgetown MS Biotechnology cost for an Indian student?

The full-route estimate is USD 98,966, about INR 95.62 lakh. It uses Georgetown’s 2026-27 published cost basis, then adds the USD 90 application, USD 350 SEVIS and USD 185 F-1 visa fees where they are outside the institutional budget.

Housing deposits, licensing or bar-exam costs, equipment and exchange spread remain outside this estimate. USD 1 = INR 96.6149, from ECB reference rates checked on 22 October 2026.

The first line uses Georgetown’s 2026-27 published basis for this route: USD 67,671. The institution may revise rates before enrolment, and extra credits or additional terms can raise the final bill.

The non-tuition model is USD 30,670 across the stated 10 months route. It follows the applicable Georgetown cost-of-attendance categories for housing, food, books, personal spending and transport rather than assuming part-time earnings.

The setup line contains the USD 90 graduate application payment, USD 350 SEVIS I-901 fee and USD 185 F-1 visa application fee. Air travel, housing deposits, professional examinations, equipment and foreign-exchange spread remain outside the total.

Can an Indian graduate meet Georgetown MS Biotechnology entry requirements?

Conditionally. The programme requires a recognised bachelor’s degree with life-science preparation and evidence of readiness for laboratory and applied biotechnology work. Georgetown then applies its international graduate rules and programme-specific selection. Meeting a published floor is eligibility evidence, not an admission prediction. The review also tests how that preparation supports the intended course sequence.

For MS Biotechnology, the transcript should make laboratory experimentation concrete before the file claims readiness for Molecular Biotechnology. A module title doesn’t prove that capability; a result, method and limitation show how the applicant actually used laboratory experimentation. The statement can then explain why Experimental Biotechnology must add biotechnology analysis now.

The application should keep three jobs separate. Transcripts establish preparation for Molecular Biotechnology; referees verify observed commercial translation; the statement connects both to the Capstone or Internship component. That chain is more persuasive for MS Biotechnology than a generic account of Georgetown, Washington, DC or the degree’s prestige.

A document map for MS Biotechnology can be literal: mark the transcript line that supports Molecular Biotechnology, attach the work sample that demonstrates laboratory experimentation, and ask a referee to verify the decision behind commercial translation. The statement should then identify why Cell and Gene Therapy is necessary before the applicant attempts Capstone or Internship. That order makes missing preparation visible early.

Four boundaries in the admission decision

1. A minimum is not an offer

   Programme fit, faculty capacity, references and the full applicant pool still affect selection.

2. Laboratory Experimentation needs evidence

   A named course, project or research result is stronger than a broad degree label for proving laboratory experimentation.

3. Research or portfolio fit is specific

   The application should connect the applicant’s record to the Capstone or Internship requirement.

4. Work rights are separate

   Admission does not settle visa issuance, OPT, employment, sponsorship or permanent residence.

How should an Indian student apply for Georgetown MS Biotechnology?

The official application point is 1 July 2027 final deadline. Start with the live programme checklist, then submit the complete academic, programme and international file before that point. Every required item must arrive on time; the application payment does not repair a missing requirement after closure.

Establish programme fit, assemble the exact evidence, submit before 1 July 2027 final deadline, then complete offer and F-1 requirements.

The allowances are Nbyula planning estimates, not processing times published by Georgetown University.

Preparation begins with the exact MS Biotechnology evidence chain. The transcript establishes academic history, the statement explains the intended work, and referees verify observed capability; none of those documents performs the job of another.

The application is complete only when programme-specific materials are present before 1 July 2027 final deadline. A later official transcript or offer condition is different from omitting an item required for review.

After an offer, the university’s acceptance, proof-of-funding and I-20 process precede the separate SEVIS payment and visa application. Admission itself is not an immigration decision.

International applicants should not submit supporting financial and sponsorship documentation during the initial application process, but should instead wait until after an official offer of admission has been made.Georgetown graduate application information

What can Georgetown MS Biotechnology lead to?

The curriculum can support evidence for biotechnology scientist, bioprocess associate and life-science analyst directions, but these are not placement predictions. An applicant still has to meet employer or regulator standards. USCIS OPT rules govern conditional work authorisation; licensing, bar admission, hiring and sponsorship remain separate.

These are curriculum-linked directions, not measured probabilities of employment, salary, sponsorship, licensing or permanent residence.

Evidence for a biotechnology scientist direction can come from Molecular Biotechnology, provided the record identifies the applicant’s own laboratory experimentation decisions. Experimental Biotechnology serves a different purpose: it can support bioprocess associate work by showing biotechnology analysis in a result that another reader can inspect.

The BioBusiness component may strengthen a life-science analyst case through commercial translation, while Capstone or Internship can anchor discussion of biotech commercialisation associate work through project communication. These aren’t measured job probabilities for MS Biotechnology; employer standards, licensing and immigration still set independent thresholds.

A useful MS Biotechnology work sample preserves four things: the question taken from Molecular Biotechnology, the method strengthened through Experimental Biotechnology, the limitation uncovered in BioBusiness, and the final decision made during Capstone or Internship. That record lets a biotechnology scientist, bioprocess associate or life-science analyst reviewer see contribution rather than infer it from the Georgetown degree title.

Who is Georgetown MS Biotechnology for?

MS Biotechnology fits an applicant who can show laboratory experimentation, needs biotechnology analysis, accepts the Capstone or Internship component and can finance INR 95.62 lakh plus excluded costs. The strongest match can also explain why Experimental Biotechnology belongs in the intended next step.

The closest-fit applicant reaches Georgetown with evidence of laboratory experimentation, a defined need for biotechnology analysis, and a reason to complete the Capstone or Internship component. Interest in BioBusiness is not enough if the applicant would avoid Cell and Gene Therapy or has no use for the work produced there.

A weaker fit wants the label of MS Biotechnology but cannot connect Molecular Biotechnology to a prior result or Experimental Biotechnology to a future task. Financial fit is separate: the INR 95.62 lakh model needs a reserve for excluded costs and can’t rest on uncertain US earnings.

The fit conversation should name the trade-off inside MS Biotechnology. Time spent on Molecular Biotechnology and Experimental Biotechnology is valuable for an applicant seeking biotechnology analysis; the same time is wasteful for someone who already demonstrates it. Likewise, Cell and Gene Therapy belongs in the plan only when the intended biotech commercialisation associate direction can use the project communication evidence produced through Capstone or Internship.

What does Georgetown MS Biotechnology cover?

The official programme source sets out the 30-credit route summarised below. Its later components include Cell and Gene Therapy and Capstone or Internship. The rows distinguish named subjects, assessed work and the culminating requirement; they form an academic map, not a promise that every elective runs in every term.

The note “Named course, requirement or programme component” applies to 5 components in this table.

• Complete at least 30 approved graduate credits.
• Follow the full-time professionally oriented plan and its academic standing rules.
• Complete 30 credits in a selected track with applied laboratory, business or industry-facing work.

Molecular Biotechnology establishes one part of the programme’s method base, while Experimental Biotechnology develops the second. Their practical value depends on the actual assignment, approved research or project plan and the standard applied to the final work.

The degree culminates in 30 credits in a selected track with applied laboratory, business or industry-facing work. Adviser capacity, elective availability, ethics approval, internship placement or production resources can affect the individual sequence where relevant.

Georgetown may revise course availability and sequencing before enrolment. The admitted student’s written plan and current catalog govern the final combination rather than an editorial sample assembled in advance.

Should an Indian student shortlist Georgetown MS Biotechnology?

The decision hinge for MS Biotechnology is whether earlier laboratory experimentation work can progress through Experimental Biotechnology into the Capstone or Internship component. The INR 95.62 lakh plan only makes sense when that academic move and the financing plan are both credible.

A strong yes-case for MS Biotechnology starts with inspectable laboratory experimentation, adds the missing biotechnology analysis demanded by Experimental Biotechnology, and uses Capstone or Internship to preserve evidence of project communication. That sequence can support a later biotechnology scientist or bioprocess associate application without turning either occupation into a promised result.

Reject this option when Molecular Biotechnology repeats completed study, when Cell and Gene Therapy is outside the intended work, or when the applicant does not want the Capstone or Internship requirement. It is also the wrong financial choice if the INR 95.62 lakh estimate depends on a guaranteed biotechnology scientist salary, because Georgetown publishes no such guarantee.

Sources

These sources support the programme, admission, cost and immigration information used on this page.

Sources checked on October 22, 2026. Current intake information follows. Fall 2027 full-time intake.